These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17545532)

  • 61. Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results.
    Thoresen L; Frykholm G; Lydersen S; Ulveland H; Baracos V; Prado CM; Birdsell L; Falkmer U
    Clin Nutr; 2013 Feb; 32(1):65-72. PubMed ID: 22695408
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Understanding the mechanisms and treatment options in cancer cachexia.
    Fearon K; Arends J; Baracos V
    Nat Rev Clin Oncol; 2013 Feb; 10(2):90-9. PubMed ID: 23207794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.
    Dewys WD; Begg C; Lavin PT; Band PR; Bennett JM; Bertino JR; Cohen MH; Douglass HO; Engstrom PF; Ezdinli EZ; Horton J; Johnson GJ; Moertel CG; Oken MM; Perlia C; Rosenbaum C; Silverstein MN; Skeel RT; Sponzo RW; Tormey DC
    Am J Med; 1980 Oct; 69(4):491-7. PubMed ID: 7424938
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment of nutritional status in cancer--the relationship between body composition and pharmacokinetics.
    Prado CM; Maia YL; Ormsbee M; Sawyer MB; Baracos VE
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1197-203. PubMed ID: 23919745
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
    Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
    Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
    Prado CM; Cushen SJ; Orsso CE; Ryan AM
    Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later.
    Ryan AM; Power DG; Daly L; Cushen SJ; Ní Bhuachalla Ē; Prado CM
    Proc Nutr Soc; 2016 May; 75(2):199-211. PubMed ID: 26786393
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
    Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
    Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study.
    Antoun S; Birdsell L; Sawyer MB; Venner P; Escudier B; Baracos VE
    J Clin Oncol; 2010 Feb; 28(6):1054-60. PubMed ID: 20085939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.
    Voron T; Tselikas L; Pietrasz D; Pigneur F; Laurent A; Compagnon P; Salloum C; Luciani A; Azoulay D
    Ann Surg; 2015 Jun; 261(6):1173-83. PubMed ID: 24950264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.
    Lieffers JR; Mourtzakis M; Hall KD; McCargar LJ; Prado CM; Baracos VE
    Am J Clin Nutr; 2009 Apr; 89(4):1173-9. PubMed ID: 19244378
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach.
    Stretch C; Eastman T; Mandal R; Eisner R; Wishart DS; Mourtzakis M; Prado CM; Damaraju S; Ball RO; Greiner R; Baracos VE
    J Nutr; 2012 Jan; 142(1):14-21. PubMed ID: 22157537
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.
    Blauwhoff-Buskermolen S; Versteeg KS; de van der Schueren MA; den Braver NR; Berkhof J; Langius JA; Verheul HM
    J Clin Oncol; 2016 Apr; 34(12):1339-44. PubMed ID: 26903572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
    Andreyev HJ; Norman AR; Oates J; Cunningham D
    Eur J Cancer; 1998 Mar; 34(4):503-9. PubMed ID: 9713300
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.
    Prado CM; Lima IS; Baracos VE; Bies RR; McCargar LJ; Reiman T; Mackey JR; Kuzma M; Damaraju VL; Sawyer MB
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):93-101. PubMed ID: 20204364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
    Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
    Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer.
    Antoun S; Borget I; Lanoy E
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):383-9. PubMed ID: 24189893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review.
    Gibson DJ; Burden ST; Strauss BJ; Todd C; Lal S
    Eur J Clin Nutr; 2015 Oct; 69(10):1079-86. PubMed ID: 25782424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy.
    Parsons HA; Tsimberidou AM; Pontikos M; Fu S; Hong D; Wen S; Baracos VE; Kurzrock R
    Nutr Cancer; 2012; 64(2):206-17. PubMed ID: 22229660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.